Read + Share
Nakazono M, Urabe F, Iwatani K, Imai Y, et al. Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy
have an extremely low risk of subsequent recurrence. Int J Urol 2023;30:1147-1154.
PMID: 37650359
|
 |
|
Nakazono M, Urabe F, Iwatani K, Imai Y, et al. Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy
have an extremely low risk of subsequent recurrence. Int J Urol 2023;30:1147-1154.
PMID: 37650359
|
|
|
|